I was listening to a reporter reviewing corporate performance over the past year and when he reviewed Pfizer he said it would be difficult for them to repeat the past year because sales of their Covid drug would decline. The question was what will Pfizer do to fill in the gap?

I volunteer apabetalone to fill needs they are not currently addressing and perhaps even get BoM2 started.

Another poor week for the SP....oh well.

GLTA

Toinv